Literature DB >> 36264423

Association between body mass index and irritable bowel syndrome in the young Japanese population: a cross-sectional study.

Yasunori Yamamoto1, Shinya Furukawa2, Junichi Watanabe3, Aki Kato4, Katsunori Kusumoto4, Teruki Miyake5, Eiji Takeshita6, Yoshio Ikeda1, Naofumi Yamamoto7, Yuka Saeki4,8, Yoichi Hiasa5.   

Abstract

PURPOSE: The association between body mass index (BMI) and irritable bowel syndrome (IBS) has been inconsistent in the Asian population. Also, no evidence regarding this issue in the young population exists. The aim of the present study is to investigate the association between BMI and IBS based on the Rome III criteria in young Japanese people.
METHODS: This study was a cross-sectional study consisted of 8923 Japanese university students. The definition of IBS was based on the Rome III criteria. BMI was divided into four categories (quartiles) on the basis of the study subjects' distribution (lowest, low, moderate, and high [reference]). The definition of lean, normal, and overweight was BMI < 18.5 kg/m2, 18.5 ≤ BMI < 25 kg/m2 (reference), and 25 ≤ BMI kg/m2, respectively. Age, sex, drinking, smoking, exercise habit, anemia, and sports injury were selected a priori as potential confounding factors.
RESULTS: The prevalence of IBS was 6.5%, with females having a significantly higher prevalence than males (6.0% vs. 7.2%, p = 0.029). In females, being overweight was independently positively associated with IBS after adjustment (adjusted odds ratio [OR]: 1.81 [95% confidence interval (CI): 1.13-2.79]). In contrast, in males, no association between being lean or overweight and IBS was found.
CONCLUSIONS: Among the young Japanese population, being overweight might be independently positively associated with prevalence of IBS in females but not in males.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Body mass index; Female; Irritable bowel syndrome; Obesity

Year:  2022        PMID: 36264423     DOI: 10.1007/s00384-022-04267-8

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.796


  28 in total

Review 1.  Diagnosis and management of irritable bowel syndrome: a guide for the generalist.

Authors:  Ecushla C Linedale; Jane M Andrews
Journal:  Med J Aust       Date:  2017-09-02       Impact factor: 7.738

2.  Prevalence of overlaps between GERD, FD and IBS and impact on health-related quality of life.

Authors:  Makiko Kaji; Yasuhiro Fujiwara; Masatsugu Shiba; Yukie Kohata; Hirokazu Yamagami; Tetsuya Tanigawa; Kenji Watanabe; Toshio Watanabe; Kazunari Tominaga; Tetsuo Arakawa
Journal:  J Gastroenterol Hepatol       Date:  2010-06       Impact factor: 4.029

3.  Epidemiology of irritable bowel syndrome in Croatia.

Authors:  M Baretić; A Bilić; D Jurcić; M Mihanović; M Sunić-Omejc; Z Dorosulić; B Restek-Petrović
Journal:  Coll Antropol       Date:  2002-12

4.  Health-related quality of life among persons with irritable bowel syndrome: a systematic review.

Authors:  H B El-Serag; K Olden; D Bjorkman
Journal:  Aliment Pharmacol Ther       Date:  2002-06       Impact factor: 8.171

Review 5.  Irritable bowel syndrome.

Authors:  Paul Enck; Qasim Aziz; Giovanni Barbara; Adam D Farmer; Shin Fukudo; Emeran A Mayer; Beate Niesler; Eamonn M M Quigley; Mirjana Rajilić-Stojanović; Michael Schemann; Juliane Schwille-Kiuntke; Magnus Simren; Stephan Zipfel; Robin C Spiller
Journal:  Nat Rev Dis Primers       Date:  2016-03-24       Impact factor: 52.329

6.  The impact of irritable bowel syndrome on health-related quality of life.

Authors:  I M Gralnek; R D Hays; A Kilbourne; B Naliboff; E A Mayer
Journal:  Gastroenterology       Date:  2000-09       Impact factor: 22.682

7.  Predictors of Health-related Quality of Life in Irritable Bowel Syndrome Patients Compared With Healthy Individuals.

Authors:  Raymond Addante; Bruce Naliboff; Wendy Shih; Angela P Presson; Kirsten Tillisch; Emeran A Mayer; Lin Chang
Journal:  J Clin Gastroenterol       Date:  2019-04       Impact factor: 3.062

Review 8.  Review article: the incidence and risk factors for irritable bowel syndrome in population-based studies.

Authors:  Francis Creed
Journal:  Aliment Pharmacol Ther       Date:  2019-07-17       Impact factor: 8.171

9.  Polycystic ovary syndrome is associated with an increased prevalence of irritable bowel syndrome.

Authors:  Ruchi Mathur; Ara Ko; Laura J Hwang; Kimberly Low; Ricardo Azziz; Mark Pimentel
Journal:  Dig Dis Sci       Date:  2009-08-21       Impact factor: 3.199

10.  Gastrointestinal symptoms are more intense in morbidly obese patients.

Authors:  A Foster; W O Richards; J McDowell; H L Laws; R H Clements
Journal:  Surg Endosc       Date:  2003-06-19       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.